Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Impedimed Limited ( (AU:IPD) ) just unveiled an update.
Impedimed Limited announced a proposed issue of securities, with a maximum of 12,491,870 warrants set to be issued. This strategic move aims to bolster the company’s financial position, potentially enhancing its operational capabilities and market competitiveness within the medical technology industry.
More about Impedimed Limited
Impedimed Limited operates within the medical technology industry, primarily focusing on the development of non-invasive medical devices for the assessment of fluid status and body composition. These devices serve various sectors within the healthcare market, including oncology, renal and heart failure management, and lymphedema diagnosis.
YTD Price Performance: -10.0%
Average Trading Volume: 33,136
Technical Sentiment Consensus Rating: Buy
Current Market Cap: $64.61M
See more insights into IPD stock on TipRanks’ Stock Analysis page.